Indivior Pharmaceuticals (INDV) has announced the pricing of its offering of $450M in convertible senior notes due in 2031. The offering size was increased from an initial amount of $400M.

PAR Technology Corporation (NYSE: PAR) ("PAR" or the "Company") announced today its intention to offer $225.0 million ...

PAR Technology (PAR) has priced a private offering of $250M aggregate principal amount of 4.00% Convertible Senior Notes due 2031. The company also granted to the initial purchasers of the notes a ...

Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its previously announced ...

Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced its intention to offer, subject to market and other conditions, $400,000,000 aggregate principal amount of convertible senior notes due ...

The notes will be senior, unsecured obligations of Indivior and will accrue interest at a rate of 0.625% per annum, payable semi-annually in arrears on March 15 and September 15 of each year, ...

CRISPR Therapeutics (CRSP) upsized a $550M convertible notes deal due 2031 at 1.125%, with a 45% conversion premium—get the key terms now.

Detailed price information for Crescent Energy Company Cl A (CRGY-N) from The Globe and Mail including charting and trades.

PAR Technology Corporation (NYSE:PAR) shares fell 10.4% Friday after the company priced a private offering of $250.0 million in 4.00% Convertible Senior Notes due ...

The gene-editing company said it intends to offer the convertible senior notes due 2031 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The ...

$1.0 billion offering of 0.25% convertible senior notes due 2032 $1.0 billion offering of 1.00% convertible senior notes due 2033 $300 million greenshoe fully exercised Capped call transactions ...

“We are extremely pleased with the outstanding response to the Convertible Note Offering from high quality institutional investors in the United States, which is a tremendous endorsement of Caledonia ...